In-Silico Drug Discovery Industry Research Report 2023
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
Highlights
The global In-Silico Drug Discovery market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by In-Silico Drug Discovery type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the In-Silico Drug Discovery are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
In-Silico Drug Discovery segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the In-Silico Drug Discovery market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the In-Silico Drug Discovery market.
In-Silico Drug Discovery Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In-Silico Drug Discovery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Silico Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of In-Silico Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the In-Silico Drug Discovery industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Silico Drug Discovery.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Silico Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global In-Silico Drug Discovery market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Charles River
- Certara USA, Inc.
- Evotec
- Dassault System (Biovia)
- Albany Molecular Research Inc. (AMRI)
- Selvita
- Schrцdinger, Inc.
- GVK BIO
- OpenEye Scientific Software
- Chemical Computing Group (CCG)
Global markets are presented by In-Silico Drug Discovery type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the In-Silico Drug Discovery are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
In-Silico Drug Discovery segment by Type
- Software as a Service (Cloud)
- Consultancy as a Service
- Software
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the In-Silico Drug Discovery market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the In-Silico Drug Discovery market.
In-Silico Drug Discovery Segment by Application
- Contract Research Organization
- Pharmaceutical Industry
- Academic and Research Institutes
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In-Silico Drug Discovery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Silico Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of In-Silico Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the In-Silico Drug Discovery industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Silico Drug Discovery.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Silico Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In-Silico Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In-Silico Drug Discovery Revenue Market Share by Type (2018-2023)
Table 7. Global In-Silico Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In-Silico Drug Discovery Revenue Market Share by Type (2024-2029)
Table 9. Global In-Silico Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global In-Silico Drug Discovery Revenue Market Share by Application (2018-2023)
Table 11. Global In-Silico Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global In-Silico Drug Discovery Revenue Market Share by Application (2024-2029)
Table 13. Global In-Silico Drug Discovery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In-Silico Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In-Silico Drug Discovery Market Share by Region (2018-2023)
Table 16. Global In-Silico Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In-Silico Drug Discovery Market Share by Region (2024-2029)
Table 18. In-Silico Drug Discovery Market Trends
Table 19. In-Silico Drug Discovery Market Drivers
Table 20. In-Silico Drug Discovery Market Challenges
Table 21. In-Silico Drug Discovery Market Restraints
Table 22. Global Top In-Silico Drug Discovery Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In-Silico Drug Discovery Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In-Silico Drug Discovery Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In-Silico Drug Discovery, Headquarters and Area Served
Table 26. Global In-Silico Drug Discovery Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In-Silico Drug Discovery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. Charles River Company Detail
Table 46. Charles River Business Overview
Table 47. Charles River In-Silico Drug Discovery Product
Table 48. Charles River Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 49. Charles River Recent Development
Table 50. Certara USA, Inc. Company Detail
Table 51. Certara USA, Inc. Business Overview
Table 52. Certara USA, Inc. In-Silico Drug Discovery Product
Table 53. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 54. Certara USA, Inc. Recent Development
Table 55. Evotec Company Detail
Table 56. Evotec Business Overview
Table 57. Evotec In-Silico Drug Discovery Product
Table 58. Evotec Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 59. Evotec Recent Development
Table 60. Dassault System (Biovia) Company Detail
Table 61. Dassault System (Biovia) Business Overview
Table 62. Dassault System (Biovia) In-Silico Drug Discovery Product
Table 63. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 64. Dassault System (Biovia) Recent Development
Table 65. Albany Molecular Research Inc. (AMRI) Company Detail
Table 66. Albany Molecular Research Inc. (AMRI) Business Overview
Table 67. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product
Table 68. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 69. Albany Molecular Research Inc. (AMRI) Recent Development
Table 70. Selvita Company Detail
Table 71. Selvita Business Overview
Table 72. Selvita In-Silico Drug Discovery Product
Table 73. Selvita Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 74. Selvita Recent Development
Table 75. Schrцdinger, Inc. Company Detail
Table 76. Schrцdinger, Inc. Business Overview
Table 77. Schrцdinger, Inc. In-Silico Drug Discovery Product
Table 78. Schrцdinger, Inc. Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 79. Schrцdinger, Inc. Recent Development
Table 80. GVK BIO Company Detail
Table 81. GVK BIO Business Overview
Table 82. GVK BIO In-Silico Drug Discovery Product
Table 83. GVK BIO Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 84. GVK BIO Recent Development
Table 85. OpenEye Scientific Software Company Detail
Table 86. OpenEye Scientific Software Business Overview
Table 87. OpenEye Scientific Software In-Silico Drug Discovery Product
Table 88. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 89. OpenEye Scientific Software Recent Development
Table 90. Chemical Computing Group (CCG) Company Detail
Table 91. Chemical Computing Group (CCG) Business Overview
Table 92. Chemical Computing Group (CCG) In-Silico Drug Discovery Product
Table 93. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 94. Chemical Computing Group (CCG) Recent Development
Table 95. Charles River Company Information
Table 96. Charles River Business Overview
Table 97. Charles River In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 98. Charles River Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 99. Charles River Recent Development
Table 100. Certara USA, Inc. Company Information
Table 101. Certara USA, Inc. Business Overview
Table 102. Certara USA, Inc. In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 103. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 104. Certara USA, Inc. Recent Development
Table 105. Evotec Company Information
Table 106. Evotec Business Overview
Table 107. Evotec In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 108. Evotec Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 109. Evotec Recent Development
Table 110. Dassault System (Biovia) Company Information
Table 111. Dassault System (Biovia) Business Overview
Table 112. Dassault System (Biovia) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 113. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 114. Dassault System (Biovia) Recent Development
Table 115. Albany Molecular Research Inc. (AMRI) Company Information
Table 116. Albany Molecular Research Inc. (AMRI) Business Overview
Table 117. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 118. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 119. Albany Molecular Research Inc. (AMRI) Recent Development
Table 120. Selvita Company Information
Table 121. Selvita Business Overview
Table 122. Selvita In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 123. Selvita Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 124. Selvita Recent Development
Table 125. Schrцdinger, Inc. Company Information
Table 126. Schrцdinger, Inc. Business Overview
Table 127. Schrцdinger, Inc. In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 128. Schrцdinger, Inc. Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 129. Schrцdinger, Inc. Recent Development
Table 130. GVK BIO Company Information
Table 131. GVK BIO Business Overview
Table 132. GVK BIO In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 133. GVK BIO Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 134. GVK BIO Recent Development
Table 135. OpenEye Scientific Software Company Information
Table 136. OpenEye Scientific Software Business Overview
Table 137. OpenEye Scientific Software In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 138. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 139. OpenEye Scientific Software Recent Development
Table 140. Chemical Computing Group (CCG) Company Information
Table 141. Chemical Computing Group (CCG) Business Overview
Table 142. Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 143. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 144. Chemical Computing Group (CCG) Recent Development
Table 145. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In-Silico Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In-Silico Drug Discovery Revenue Market Share by Type (2018-2023)
Table 7. Global In-Silico Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In-Silico Drug Discovery Revenue Market Share by Type (2024-2029)
Table 9. Global In-Silico Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global In-Silico Drug Discovery Revenue Market Share by Application (2018-2023)
Table 11. Global In-Silico Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global In-Silico Drug Discovery Revenue Market Share by Application (2024-2029)
Table 13. Global In-Silico Drug Discovery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In-Silico Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In-Silico Drug Discovery Market Share by Region (2018-2023)
Table 16. Global In-Silico Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In-Silico Drug Discovery Market Share by Region (2024-2029)
Table 18. In-Silico Drug Discovery Market Trends
Table 19. In-Silico Drug Discovery Market Drivers
Table 20. In-Silico Drug Discovery Market Challenges
Table 21. In-Silico Drug Discovery Market Restraints
Table 22. Global Top In-Silico Drug Discovery Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In-Silico Drug Discovery Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In-Silico Drug Discovery Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In-Silico Drug Discovery, Headquarters and Area Served
Table 26. Global In-Silico Drug Discovery Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In-Silico Drug Discovery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In-Silico Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. Charles River Company Detail
Table 46. Charles River Business Overview
Table 47. Charles River In-Silico Drug Discovery Product
Table 48. Charles River Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 49. Charles River Recent Development
Table 50. Certara USA, Inc. Company Detail
Table 51. Certara USA, Inc. Business Overview
Table 52. Certara USA, Inc. In-Silico Drug Discovery Product
Table 53. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 54. Certara USA, Inc. Recent Development
Table 55. Evotec Company Detail
Table 56. Evotec Business Overview
Table 57. Evotec In-Silico Drug Discovery Product
Table 58. Evotec Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 59. Evotec Recent Development
Table 60. Dassault System (Biovia) Company Detail
Table 61. Dassault System (Biovia) Business Overview
Table 62. Dassault System (Biovia) In-Silico Drug Discovery Product
Table 63. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 64. Dassault System (Biovia) Recent Development
Table 65. Albany Molecular Research Inc. (AMRI) Company Detail
Table 66. Albany Molecular Research Inc. (AMRI) Business Overview
Table 67. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product
Table 68. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 69. Albany Molecular Research Inc. (AMRI) Recent Development
Table 70. Selvita Company Detail
Table 71. Selvita Business Overview
Table 72. Selvita In-Silico Drug Discovery Product
Table 73. Selvita Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 74. Selvita Recent Development
Table 75. Schrцdinger, Inc. Company Detail
Table 76. Schrцdinger, Inc. Business Overview
Table 77. Schrцdinger, Inc. In-Silico Drug Discovery Product
Table 78. Schrцdinger, Inc. Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 79. Schrцdinger, Inc. Recent Development
Table 80. GVK BIO Company Detail
Table 81. GVK BIO Business Overview
Table 82. GVK BIO In-Silico Drug Discovery Product
Table 83. GVK BIO Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 84. GVK BIO Recent Development
Table 85. OpenEye Scientific Software Company Detail
Table 86. OpenEye Scientific Software Business Overview
Table 87. OpenEye Scientific Software In-Silico Drug Discovery Product
Table 88. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 89. OpenEye Scientific Software Recent Development
Table 90. Chemical Computing Group (CCG) Company Detail
Table 91. Chemical Computing Group (CCG) Business Overview
Table 92. Chemical Computing Group (CCG) In-Silico Drug Discovery Product
Table 93. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2017-2022) & (US$ Million)
Table 94. Chemical Computing Group (CCG) Recent Development
Table 95. Charles River Company Information
Table 96. Charles River Business Overview
Table 97. Charles River In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 98. Charles River Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 99. Charles River Recent Development
Table 100. Certara USA, Inc. Company Information
Table 101. Certara USA, Inc. Business Overview
Table 102. Certara USA, Inc. In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 103. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 104. Certara USA, Inc. Recent Development
Table 105. Evotec Company Information
Table 106. Evotec Business Overview
Table 107. Evotec In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 108. Evotec Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 109. Evotec Recent Development
Table 110. Dassault System (Biovia) Company Information
Table 111. Dassault System (Biovia) Business Overview
Table 112. Dassault System (Biovia) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 113. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 114. Dassault System (Biovia) Recent Development
Table 115. Albany Molecular Research Inc. (AMRI) Company Information
Table 116. Albany Molecular Research Inc. (AMRI) Business Overview
Table 117. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 118. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 119. Albany Molecular Research Inc. (AMRI) Recent Development
Table 120. Selvita Company Information
Table 121. Selvita Business Overview
Table 122. Selvita In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 123. Selvita Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 124. Selvita Recent Development
Table 125. Schrцdinger, Inc. Company Information
Table 126. Schrцdinger, Inc. Business Overview
Table 127. Schrцdinger, Inc. In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 128. Schrцdinger, Inc. Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 129. Schrцdinger, Inc. Recent Development
Table 130. GVK BIO Company Information
Table 131. GVK BIO Business Overview
Table 132. GVK BIO In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 133. GVK BIO Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 134. GVK BIO Recent Development
Table 135. OpenEye Scientific Software Company Information
Table 136. OpenEye Scientific Software Business Overview
Table 137. OpenEye Scientific Software In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 138. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 139. OpenEye Scientific Software Recent Development
Table 140. Chemical Computing Group (CCG) Company Information
Table 141. Chemical Computing Group (CCG) Business Overview
Table 142. Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million)
Table 143. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2018-2023) & (US$ Million) Portfolio
Table 144. Chemical Computing Group (CCG) Recent Development
Table 145. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. In-Silico Drug Discovery Product Picture
Figure 5. Global In-Silico Drug Discovery Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global In-Silico Drug Discovery Market Share by Type: 2022 VS 2029
Figure 7. Software as a Service (Cloud) Product Picture
Figure 8. Consultancy as a Service Product Picture
Figure 9. Software Product Picture
Figure 10. Global In-Silico Drug Discovery Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global In-Silico Drug Discovery Market Share by Application: 2022 VS 2029
Figure 12. Contract Research Organization Product Picture
Figure 13. Pharmaceutical Industry Product Picture
Figure 14. Academic and Research Institutes Product Picture
Figure 15. Others Product Picture
Figure 16. Global In-Silico Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global In-Silico Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global In-Silico Drug Discovery Market Share by Region: 2022 VS 2029
Figure 19. Global In-Silico Drug Discovery Market Share by Players in 2022
Figure 20. Global In-Silico Drug Discovery Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 In-Silico Drug Discovery Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 25. United States In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 29. Germany In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 37. China In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 45. Mexico In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 49. Turkey In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Charles River Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 53. Certara USA, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 54. Evotec Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 55. Dassault System (Biovia) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 56. Albany Molecular Research Inc. (AMRI) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 57. Selvita Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 58. Schrцdinger, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 59. GVK BIO Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 60. OpenEye Scientific Software Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 61. Chemical Computing Group (CCG) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. In-Silico Drug Discovery Product Picture
Figure 5. Global In-Silico Drug Discovery Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global In-Silico Drug Discovery Market Share by Type: 2022 VS 2029
Figure 7. Software as a Service (Cloud) Product Picture
Figure 8. Consultancy as a Service Product Picture
Figure 9. Software Product Picture
Figure 10. Global In-Silico Drug Discovery Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global In-Silico Drug Discovery Market Share by Application: 2022 VS 2029
Figure 12. Contract Research Organization Product Picture
Figure 13. Pharmaceutical Industry Product Picture
Figure 14. Academic and Research Institutes Product Picture
Figure 15. Others Product Picture
Figure 16. Global In-Silico Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global In-Silico Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global In-Silico Drug Discovery Market Share by Region: 2022 VS 2029
Figure 19. Global In-Silico Drug Discovery Market Share by Players in 2022
Figure 20. Global In-Silico Drug Discovery Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 In-Silico Drug Discovery Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 25. United States In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 29. Germany In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 37. China In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 45. Mexico In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa In-Silico Drug Discovery Market Share by Country (2018-2029)
Figure 49. Turkey In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE In-Silico Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Charles River Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 53. Certara USA, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 54. Evotec Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 55. Dassault System (Biovia) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 56. Albany Molecular Research Inc. (AMRI) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 57. Selvita Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 58. Schrцdinger, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 59. GVK BIO Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 60. OpenEye Scientific Software Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
Figure 61. Chemical Computing Group (CCG) Revenue Growth Rate in In-Silico Drug Discovery Business (2018-2023)
